课题基金 / 基金详情

项目摘要

项目成果

Frederic D Bushman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY- CORE B (GENOMICS CORE) Core B (Genomics Core) will provide key support to the mVACS team in Clostridioides difficile genome sequence analysis, antigen design, microbiome sequence analysis, routine statistical analysis, and high content data management. Core B will use advanced genomics-based methods to quantify C. difficile genome composition and genetic variation, and associate these with outcomes. Core B will support analysis of protein structure to allow expression of well-folded domains as mRNAs. Core B will characterize DNA inversion systems and other mechanisms of DNA modification and alterations in gene activity that may impact vaccine efficacy. Core B will also carry out transcriptional profiling on C. difficile isolated from the intestine of vaccinated and immunodeficient mice, to assess how C. difficile responds in vivo to effective and ineffective immune responses. The Aims of Core B are: (1) C. difficile genomics to identify optimal targets for modified mRNA vaccines. Long read and short read data will be merged to generate complete assemblies, as in our previous work. Gene content will be enumerated and compared with clinical outcomes. (2) To assess variation in sequence and abundance of C. difficile vaccine targets. C. difficile isolates are known to encode considerable variation in their surface proteins. In addition, DNA inversion systems encode on-off switches affecting surface proteins and transcription factors, resulting in extensive population heterogeneity. This Aim will thus carry out deep assessment of proteins relevant as modified mRNA vaccine targets, and guide antigen design. (3) Transcriptional profiling and microbiome sequencing for mechanistic investigation. Projects 1-3 and the Clinical Core will generate murine and human fecal samples associated with successful or unsuccessful responses to C. difficile infection; Core B will quantify microbiome composition and metatranscriptomic analysis of C. difficile positive samples by RNA-seq. This core will oversee sequence acquisition and analysis is support of these studies. (4) Data management and archiving. Core C will work with Core A for standard statistical analysis and will archive and manage the diverse data types generated by the U19 team.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
mVACS--mRNA Vaccines for C. difficile Suppression
  • 批准号:
    10625573
  • 项目类别:
  • 资助金额:
    $153.0万
  • 财政年份:
    2023
  • 负责人:
    Frederic D Bushman
  • 依托单位:
Preserving Genome Integrity In AAV-Mediated Gene Therapy
  • 批准号:
    10338480
  • 项目类别:
  • 资助金额:
    $63.15万
  • 财政年份:
    2022
  • 负责人:
    Frederic D Bushman
  • 依托单位:
Preserving Genome Integrity In AAV-Mediated Gene Therapy
  • 批准号:
    10558679
  • 项目类别:
  • 资助金额:
    $64.52万
  • 财政年份:
    2022
  • 负责人:
    Frederic D Bushman
  • 依托单位:
Core B: Genome Engineering Core
  • 批准号:
    10450647
  • 项目类别:
  • 资助金额:
    $16.65万
  • 财政年份:
    2020
  • 负责人:
    Frederic D Bushman
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究